vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.
TOOTSIE ROLL INDUSTRIES INC is the larger business by last-quarter revenue ($196.3M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). TOOTSIE ROLL INDUSTRIES INC runs the higher net margin — 14.7% vs -82.0%, a 96.6% gap on every dollar of revenue. On growth, TOOTSIE ROLL INDUSTRIES INC posted the faster year-over-year revenue change (1.5% vs -22.7%). TOOTSIE ROLL INDUSTRIES INC produced more free cash flow last quarter ($61.0M vs $-36.6M). Over the past eight quarters, TOOTSIE ROLL INDUSTRIES INC's revenue compounded faster (13.2% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
PTCT vs TR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $196.3M |
| Net Profit | $-135.0M | $28.8M |
| Gross Margin | — | 35.7% |
| Operating Margin | -43.3% | 17.0% |
| Net Margin | -82.0% | 14.7% |
| Revenue YoY | -22.7% | 1.5% |
| Net Profit YoY | -104.8% | 27.9% |
| EPS (diluted) | $-1.63 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $196.3M | ||
| Q3 25 | $211.0M | $232.7M | ||
| Q2 25 | $178.9M | $155.1M | ||
| Q1 25 | $1.2B | $148.5M | ||
| Q4 24 | $213.2M | $193.4M | ||
| Q3 24 | $196.8M | $225.9M | ||
| Q2 24 | $186.7M | $150.7M | ||
| Q1 24 | $210.1M | $153.2M |
| Q4 25 | $-135.0M | $28.8M | ||
| Q3 25 | $15.9M | $35.7M | ||
| Q2 25 | $-64.8M | $17.5M | ||
| Q1 25 | $866.6M | $18.1M | ||
| Q4 24 | $-65.9M | $22.5M | ||
| Q3 24 | $-106.7M | $32.8M | ||
| Q2 24 | $-99.2M | $15.6M | ||
| Q1 24 | $-91.6M | $15.8M |
| Q4 25 | — | 35.7% | ||
| Q3 25 | — | 34.1% | ||
| Q2 25 | — | 36.4% | ||
| Q1 25 | — | 35.3% | ||
| Q4 24 | — | 39.1% | ||
| Q3 24 | — | 34.1% | ||
| Q2 24 | — | 33.5% | ||
| Q1 24 | — | 32.7% |
| Q4 25 | -43.3% | 17.0% | ||
| Q3 25 | 1.4% | 13.9% | ||
| Q2 25 | -19.5% | 7.8% | ||
| Q1 25 | 82.5% | 15.5% | ||
| Q4 24 | -76.2% | 20.0% | ||
| Q3 24 | -27.7% | 15.6% | ||
| Q2 24 | -21.5% | 10.2% | ||
| Q1 24 | -21.6% | 7.3% |
| Q4 25 | -82.0% | 14.7% | ||
| Q3 25 | 7.5% | 15.3% | ||
| Q2 25 | -36.3% | 11.3% | ||
| Q1 25 | 73.7% | 12.2% | ||
| Q4 24 | -30.9% | 11.6% | ||
| Q3 24 | -54.2% | 14.5% | ||
| Q2 24 | -53.1% | 10.4% | ||
| Q1 24 | -43.6% | 10.3% |
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $0.20 | — | ||
| Q2 25 | $-0.83 | — | ||
| Q1 25 | $10.04 | — | ||
| Q4 24 | $-0.85 | — | ||
| Q3 24 | $-1.39 | — | ||
| Q2 24 | $-1.29 | — | ||
| Q1 24 | $-1.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $176.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $941.0M |
| Total Assets | $2.9B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $176.6M | ||
| Q3 25 | $1.7B | $119.8M | ||
| Q2 25 | $2.0B | $170.5M | ||
| Q1 25 | $2.0B | $176.6M | ||
| Q4 24 | $1.1B | $194.6M | ||
| Q3 24 | $1.0B | $163.2M | ||
| Q2 24 | $1.1B | $131.2M | ||
| Q1 24 | $884.8M | $159.4M |
| Q4 25 | $-205.3M | $941.0M | ||
| Q3 25 | $-155.8M | $918.9M | ||
| Q2 25 | $-206.5M | $893.1M | ||
| Q1 25 | $-185.8M | $879.4M | ||
| Q4 24 | $-1.1B | $870.7M | ||
| Q3 24 | $-1.1B | $870.2M | ||
| Q2 24 | $-980.2M | $841.4M | ||
| Q1 24 | $-893.9M | $834.4M |
| Q4 25 | $2.9B | $1.3B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.1B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $1.9B | $1.1B | ||
| Q1 24 | $1.8B | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $73.3M |
| Free Cash FlowOCF − Capex | $-36.6M | $61.0M |
| FCF MarginFCF / Revenue | -22.3% | 31.1% |
| Capex IntensityCapex / Revenue | 1.4% | 6.3% |
| Cash ConversionOCF / Net Profit | — | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $96.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $73.3M | ||
| Q3 25 | $-66.3M | $62.2M | ||
| Q2 25 | $-58.3M | $-8.5M | ||
| Q1 25 | $870.1M | $3.6M | ||
| Q4 24 | $-30.0M | $68.8M | ||
| Q3 24 | $-77.0M | $61.3M | ||
| Q2 24 | $-71.5M | $-12.6M | ||
| Q1 24 | $70.8M | $21.4M |
| Q4 25 | $-36.6M | $61.0M | ||
| Q3 25 | $-69.7M | $50.7M | ||
| Q2 25 | $-59.6M | $-16.0M | ||
| Q1 25 | $868.4M | $750.0K | ||
| Q4 24 | $-33.8M | $64.7M | ||
| Q3 24 | $-77.5M | $55.8M | ||
| Q2 24 | $-78.8M | $-16.6M | ||
| Q1 24 | $61.2M | $16.9M |
| Q4 25 | -22.3% | 31.1% | ||
| Q3 25 | -33.1% | 21.8% | ||
| Q2 25 | -33.3% | -10.3% | ||
| Q1 25 | 73.8% | 0.5% | ||
| Q4 24 | -15.8% | 33.5% | ||
| Q3 24 | -39.4% | 24.7% | ||
| Q2 24 | -42.2% | -11.0% | ||
| Q1 24 | 29.1% | 11.0% |
| Q4 25 | 1.4% | 6.3% | ||
| Q3 25 | 1.6% | 5.0% | ||
| Q2 25 | 0.7% | 4.8% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 1.8% | 2.1% | ||
| Q3 24 | 0.3% | 2.4% | ||
| Q2 24 | 4.0% | 2.6% | ||
| Q1 24 | 4.6% | 2.9% |
| Q4 25 | — | 2.55× | ||
| Q3 25 | -4.17× | 1.74× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | 1.00× | 0.20× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | -0.81× | ||
| Q1 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
TR
| Products | $194.3M | 99% |
| Rental And Royalty | $1.9M | 1% |
